Physician profile
Nancy E Johnson
NPI 1972676260
$5,210.22
in general payments reported to CMS, 2019-2025
39 companies · $897 in 2025
The $897 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,277 · 2022: $1,035 · 2023: $910 · 2024: $1,092 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,885 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,884.56 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $813.77 | 2021-2025 | |
| Novo Nordisk INC | $535.05 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $428.91 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Merck Sharp & Dohme LLC | $413.53 | 2021-2023 | Belsomra, Steglatro, Dificid |
| Astrazeneca Pharmaceuticals LP | $299.19 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbott Laboratories | $295.58 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $246.31 | 2021-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $193.55 | 2021-2022 | |
| Esperion Therapeutics, INC. | $152.44 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $145.00 | 2023-2024 | Austedo Xr |
| Novartis Pharmaceuticals Corporation | $134.66 | 2022-2025 | |
| Abbvie INC. | $134.41 | 2021-2025 | |
| Glaxosmithkline, LLC. | $130.27 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $112.58 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $107.47 | 2021-2024 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.